January 16, 2025Thyroid Vol 35, No. 1 This research article investigates the potential link between glucagon-like peptide 1 receptor agonists (GLP1-RAs), medications used for type 2 diabetes, and the risk of developing thyroid cancer. Conducted as a large, international study across multiple sites in six countries, it compared GLP1-RA users with those using dipeptidyl peptidase-4 inhibitors (DPP-4is), another class … Read more
Abstract Aim Type 2 diabetes mellitus (T2DM) is associated with an increased risk of delirium and mortality. While glucagon-like peptide-1 receptor agonists (GLP-1 RAs) provide metabolic and neuroprotective benefits, their long-term impact on delirium risk remains uncertain. This study compares GLP-1 RAs and metformin in relation to delirium and mortality in T2DM patients using real-world … Read more
by Carol A Westbrook What is the hardest thing about dieting, the reason that most dieters give up? They get hungry. Wouldn’t it be great if there were a pill that would leave you satisfied after a diet meal without those hunger pangs? A medicine that would keep you on a diet and help you … Read more
A MOTHER has revealed that she was unhappy and overweight so decided to start using Mounjaro. In just seven months, thanks to the injections, Claire Walton was able to lose five stone. A mother went from unhappy and overweight to slender and confident thanks to MounjaroTiktok/@clairewalton21 Tiktok/@clairewalton21Claire Walton not only dropped five stone whilst using … Read more
One day after WeightWatchers said that it would file for bankruptcy, weight-loss drug giant Novo Nordisk’s outlook is brightening. Novo Nordisk, the Danish company that produces semaglutide drugs Ozempic and Wegovy, saw its shares rise more than 7% Wednesday, in spite of recent headwinds from widely available copycat versions of its signature weight-loss drugs. Following … Read more
Presentation by Noelia Duchovny, an analyst in CBO’s Health Analysis Division, at the National Institute of Diabetes and Digestive and Kidney Diseases Workshop on GLP-1-Based Therapies.
Ozempic and other drugs like it have been threatening the established diet industry since they premiered — and it appears that Weight Watchers is now getting the hatchet. In a note to investors, the long-running weight loss company is taking the “strategic action” of filing for bankruptcy in hopes of consolidating its immense $1.15 billion … Read more
Weightwatchers files for bankruptcy as Ozempic and Mounjaro surge in popularity BBC WeightWatchers Files Bankruptcy to Adapt to Chemically Induced Weight-Loss Future WSJ WeightWatchers Files for Bankruptcy to Reduce $1 Billion in Debt The New York Times WeightWatchers goes bankrupt, as offering GLP-1 drugs couldn’t cure its debt problems MarketWatch WeightWatchers files for bankruptcy CNN
When I give presentations about JAMA Psychiatry, people often ask me what our “strategy” is and how we decide what papers to publish. I respond that our guiding lights are scientific rigor and clinical relevance. This has never been truer than at the present time, when medical research and practice are under scrutiny like never … Read more
